Brain Imaging: Cocaine Effects & Medication Development - 5

New York State Psychiatric Institute

Status and phase: Withdrawn; Phase 4

Conditions: Cocaine-Related Disorders

Treatments: Drug: Cocaine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000270

P50-09236-5

NIDA-09236-5

5P50DA009236-18 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to define temporal profile of brain activation (rCBF) using Xenon-SPECT and O 15-PET.

Sex: All

Ages: 18 to 48 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.